Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Change in Acquisitions & Divestments: 2011-2024

Historic Change in Acquisitions & Divestments for EyePoint Pharmaceuticals (EYPT) over the last 9 years, with Dec 2024 value amounting to $183.0 million.

  • EyePoint Pharmaceuticals' Change in Acquisitions & Divestments was N/A to $2.5 million in Q2 2017 from the same period last year, while for Jun 2017 it was $18.7 million, marking a year-over-year change of. This contributed to the annual value of $183.0 million for FY2024, which is 231.02% up from last year.
  • According to the latest figures from FY2024, EyePoint Pharmaceuticals' Change in Acquisitions & Divestments is $183.0 million, which was up 231.02% from $55.3 million recorded in FY2023.
  • EyePoint Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $183.0 million during FY2024, with a 5-year trough of $55.3 million in FY2023.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $124.0 million (2022), whereas its average is $120.8 million.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Change in Acquisitions & Divestments slumped by 55.42% in 2023 and then skyrocketed by 231.02% in 2024.
  • Over the past 3 years, EyePoint Pharmaceuticals' Change in Acquisitions & Divestments (Yearly) stood at $124.0 million in 2022, then crashed by 55.42% to $55.3 million in 2023, then skyrocketed by 231.02% to $183.0 million in 2024.